|
|
|
Biological Activity:
Selective irreversible μ opioid receptor antagonist
References: online 1
JH Broadbear et al. Methocinnamox is a potent long-lasting and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine and beta-chlornaltrexamine. J. Pharmacol. Exp. Ther. 2000, 294, 933.
Chemical Name: (E)-4-[[(5α,6β)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-2-butenoic acid methyl ester hydrochloride
|
| beta-Funaltrexamine | μ opioid antagonist | Axon Medchem | Axon 1213 | beta-FNA |
|
axonmedchem.com © 2011 |
![]() |
Axon Opioid Receptor Ligands:
nor-BNI | k opioid antagonist
β-FNA | μ opioid antagonist
GNTI | k opioid antagonist
Nalmefene | opioid antagonist
Naloxonazine | opioid antagonist
Naloxone Benzoylhydrazone
ADL 5859 | δ opioid agonist
Fedotozine | kopioid agonist
SNC 80 | δ opioid agonist
U 50488 | k opioid agonist
BAN ORL 24 | NOP antagonist
JTC 801 | NOP antagonist
SB 612111 | NOP antagonist |